Compare Cytokinetics Inc (CYTK) vs GE Vernova Inc (GEV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs GE Vernova Inc — how do they compare? Cytokinetics Inc trades at $76.61 (market cap $10.63B), while GE Vernova Inc trades at $1,044.78 (market cap $269.50B). The key difference: GE Vernova Inc is far larger — about 25.4× Cytokinetics Inc's market cap, and GE Vernova Inc pays a 0.2% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | GEV | |
|---|---|---|
Market Cap | $10.63B | $269.50B |
Sector | Technology | Technology |
52-Week High | $87.26 | $1.17K |
52-Week Low | $34.31 | $547.96 |
Enterprise Value | $10.74B | $259.17B |
Dividend Yield | — | 0.2% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About GE Vernova Inc
GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.
Read more on GEV →
